Shu-Rui Li

710 total citations
17 papers, 533 citations indexed

About

Shu-Rui Li is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Shu-Rui Li has authored 17 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Organic Chemistry and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Shu-Rui Li's work include Synthesis and biological activity (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Genetic factors in colorectal cancer (3 papers). Shu-Rui Li is often cited by papers focused on Synthesis and biological activity (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Genetic factors in colorectal cancer (3 papers). Shu-Rui Li collaborates with scholars based in China, United Kingdom and Sweden. Shu-Rui Li's co-authors include Stephen A. Bustin, Sina Dorudi, Petra C. F. Oyston, Nick Dorrell, Kerstin J. Williams, Richard W. Titball, Brendan W. Wren, Michael J. Green, Cheng‐He Zhou and Ling Zhang and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Shu-Rui Li

15 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu-Rui Li China	13	275	168	88	58	54	17	533
Gang Lǚ United States	10	178 0.6×	86 0.5×	47 0.5×	23 0.4×	47 0.9×	15	552
Jessica L. Schneck United States	11	263 1.0×	32 0.2×	61 0.7×	20 0.3×	30 0.6×	22	405
Nathanael A. Caveney United States	13	255 0.9×	121 0.7×	48 0.5×	57 1.0×	68 1.3×	25	581
Daniel Andrew Aiello United States	10	253 0.9×	90 0.5×	70 0.8×	54 0.9×	18 0.3×	13	499
T. Jabeen India	16	409 1.5×	156 0.9×	92 1.0×	6 0.1×	55 1.0×	29	645
Sherry M. Carty United States	7	343 1.2×	153 0.9×	28 0.3×	100 1.7×	16 0.3×	7	491
Michael Taylor United States	17	302 1.1×	44 0.3×	38 0.4×	165 2.8×	47 0.9×	37	689
Jiyun Liu China	12	319 1.2×	103 0.6×	51 0.6×	20 0.3×	25 0.5×	18	599
Sook‐Kyung Kim South Korea	13	317 1.2×	129 0.8×	25 0.3×	20 0.3×	28 0.5×	32	513

Countries citing papers authored by Shu-Rui Li

Since Specialization

Citations

This map shows the geographic impact of Shu-Rui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Rui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Rui Li more than expected).

Fields of papers citing papers by Shu-Rui Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-Rui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Rui Li. The network helps show where Shu-Rui Li may publish in the future.

Co-authorship network of co-authors of Shu-Rui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Rui Li. A scholar is included among the top collaborators of Shu-Rui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Rui Li. Shu-Rui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Li, Shu-Rui, et al.. (2025). Discovery of benzopyronyl imidazolidinediones as new structural skeleton of potential multitargeting antibacterial agents. Bioorganic Chemistry. 164. 108923–108923. 3 indexed citations

Li, Shu-Rui, Shiyu Huang, Nisar Ahmad, et al.. (2025). Heteroarylcyanovinyl Benzimidazoles as New Antibacterial Skeleton with Large Potential To Combat Bacterial Infections. Journal of Agricultural and Food Chemistry. 73(22). 13985–13997. 6 indexed citations

Li, Liying, et al.. (2024). Dexmedetomidine Attenuates Hemodynamic and Proinflammatory Responses During Craniotomy for Traumatic Brain Injury. American Journal of Therapeutics. 32(1). e52–e56.

Li, Shu-Rui, et al.. (2024). Enzymatic synthesis of N -formylated sialosides via a five-enzyme cascade. Organic & Biomolecular Chemistry. 22(36). 7485–7491.

Zhang, Jing, et al.. (2024). Cyanomethylquinolones as a New Class of Potential Multitargeting Broad-Spectrum Antibacterial Agents. Journal of Medicinal Chemistry. 67(11). 9028–9053. 22 indexed citations

Li, Shu-Rui, et al.. (2023). Benzopyrone-mediated quinolones as potential multitargeting antibacterial agents. European Journal of Medicinal Chemistry. 262. 115878–115878. 28 indexed citations

Zhang, Jing, Shu-Rui Li, Narsaiah Battini, et al.. (2023). Discovery of benzopyridone cyanoacetates as new type of potential broad-spectrum antibacterial candidates. European Journal of Medicinal Chemistry. 265. 116107–116107. 23 indexed citations

Li, Shu-Rui, et al.. (2023). Comprehensive Insights into Medicinal Research on Imidazole-Based Supramolecular Complexes. Pharmaceutics. 15(5). 1348–1348. 50 indexed citations

Wang, Jing-Zhang, Yuhua Zhang, Yali Li, et al.. (2013). Focusing on the structure and the function of Pin1: New insights into the opposite effects of fever on cancers and Alzheimer’s disease. Medical Hypotheses. 81(2). 282–284. 13 indexed citations

10.

Wang, Jing-Zhang, Shu-Rui Li, Yali Li, et al.. (2013). Could Pin1 help us conquer essential hypertension at an earlier stage? A promising early-diagnostic biomarker and its therapeutic implications for the disease. Medical Hypotheses. 81(5). 931–935. 12 indexed citations

11.

Li, Shu-Rui, Ayan Banerjea, Shafi Ahmed, et al.. (2004). Differential Expression Patterns of the Insulin-Like Growth Factor 2 Gene in Human Colorectal Cancer. Tumor Biology. 25(1-2). 62–68. 17 indexed citations

12.

Bustin, Stephen A., Shu-Rui Li, & Sina Dorudi. (2001). Expression of the Ca ²⁺ -Activated Chloride Channel Genes CLCA1 and CLCA2 Is Downregulated in Human Colorectal Cancer. DNA and Cell Biology. 20(6). 331–338. 74 indexed citations

13.

Bustin, Stephen A., Shu-Rui Li, Simon Phillips, & Sina Dorudi. (2001). Expression of HLA Class II in Colorectal Cancer: Evidence for Enhanced Immunogenicity of Microsatellite-Instability-Positive Tumours. Tumor Biology. 22(5). 294–298. 36 indexed citations

14.

Williams, Kerstin J., Petra C. F. Oyston, Nick Dorrell, et al.. (2000). Investigation into the role of the serine protease HtrA in Yersinia pestis pathogenesis. FEMS Microbiology Letters. 186(2). 281–286. 32 indexed citations

15.

Li, Shu-Rui, et al.. (2000). Elevated Levels of RanBP7 mRNA in Colorectal Carcinoma Are Associated with Increased Proliferation and Are Similar to the Transcription Pattern of the Proto-oncogene c-myc. Biochemical and Biophysical Research Communications. 271(2). 537–543. 28 indexed citations

16.

Li, Shu-Rui, et al.. (2000). Transcription of the inositol polyphosphate 1-phosphatase gene (INPP1) is upregulated in human colorectal cancer. Molecular Carcinogenesis. 27(4). 322–329. 14 indexed citations

17.

Oyston, Petra C. F., Nick Dorrell, Kerstin J. Williams, et al.. (2000). The Response Regulator PhoP Is Important for Survival under Conditions of Macrophage-Induced Stress and Virulence in Yersinia pestis. Infection and Immunity. 68(6). 3419–3425. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact